ScholarGate
アシスタント

手法を比較

選択した手法を並べて確認できます。異なる行はハイライト表示されます。

EORTC QLQ-BR23:乳がんにおける生活の質×EORTC QLQ-LC13:肺癌における生活の質×
分野腫瘍学腫瘍学
系統Process / pipelineProcess / pipeline
提唱年19961994
提唱者Sprangers, M. A., et al. (EORTC Quality of Life Group)Bergman, B., et al. (EORTC Quality of Life Group)
種類Self-report questionnaireSelf-report questionnaire
原典Sprangers, M. A., Groenvold, M., Arraras, J. I., Franklin, J., te Velde, A., Muller, M., et al. (1996). The European Organization for Research and Treatment of Cancer breast cancer-specific quality-of-life questionnaire module: first results from a three-country field study. J Clin Oncol, 14(10), 2756–2768. DOI ↗Bergman, B., Aaronson, N. K., Ahmedzai, S., Kaasa, S., & Sullivan, M. (1994). The EORTC QLQ-LC13: a modular supplement to the EORTC core quality of life questionnaire (QLQ-C30) for use in lung cancer clinical trials. Eur J Cancer, 30A(5), 635–642. DOI ↗
別名QLQ-BR23QLQ-LC13
関連55
概要The EORTC QLQ-BR23 is a 23-item breast-cancer-specific module designed to complement the 30-item EORTC QLQ-C30 core questionnaire, assessing functional and symptom domains unique to breast cancer. Validated by Sprangers et al. in 1996, it measures body image, sexual function, breast symptoms, and arm symptoms, making it a standard instrument in European and international breast cancer clinical trials and quality-of-life research.The EORTC QLQ-LC13 is a 13-item lung-cancer-specific module designed to complement the 30-item EORTC QLQ-C30 core questionnaire. Developed and validated by Bergman et al. in 1994, it measures lung-specific symptoms (dyspnea, cough, hemoptysis, chest pain) and treatment toxicities (sore mouth, dysphagia). It is the standard lung cancer-specific QoL instrument in European and international trials.
ScholarGateデータセット
  1. v1
  2. 2 出典
  3. PUBLISHED
  1. v1
  2. 2 出典
  3. PUBLISHED

検索へ スライドをダウンロード

ScholarGate手法を比較: EORTC QLQ-BR23 · EORTC QLQ-LC13. 2026-06-19に以下より取得 https://scholargate.app/ja/compare